Literature DB >> 17703364

Aromatase cytochrome P450 enzyme expression in human pituitary.

Pinar Kadioglu1, Gokhan Oral, Muge Sayitoglu, Nevin Erensoy, Berna Senel, Nurperi Gazioglu, Aydin Sav, Gursel Cetin, Ugur Ozbek.   

Abstract

Aromatase (P450AROM) converts testosterone to estrogen. This conversion could be important in normal physiology and estradiol-induced tumorigenesis in human pituitary. The objective of this study was to examine the expression of P450AROM in normal human pituitary and determine the gender difference. We examined aromatase expression in 19 normal human pituitary glands [13 males, 6 females, median age: 30 years (interquartile ranges, IQR: 23-63)] obtained from autopsy. We demonstrated aromatase gene expression levels by quantitative RT-PCR and aromatase protein with immunohistochemical staining in normal male and female human pituitary. Although median relative expression level of aromatase mRNA of male individuals [median DeltaCt = 42.6 (IQR: 7.6-93.9)] was higher than the female individuals [median DeltaCt = 3.9 (IQR:0-44.8)], we could not determine a significant gender difference in aromatase mRNA levels (p = 0.2). The difference between the aromatase protein density by immunohistochemistry was not significant between genders (p = 0.78). The aromatase levels were also not correlated with the age of the study subjects (p = 0.42 r = -0.21). The results indicate that aromatase enzyme is present in human pituitary. The amount and the density of the enzyme show a large variance among different individuals. Although higher mRNA expression was observed in male pituitary compared to female pituitary, there was no statistically significant difference for gender or age.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17703364     DOI: 10.1007/s11102-007-0065-3

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  25 in total

Review 1.  Aromatase inhibitors in the treatment of breast cancer.

Authors:  Robert W Brueggemeier; John C Hackett; Edgar S Diaz-Cruz
Journal:  Endocr Rev       Date:  2005-04-06       Impact factor: 19.871

2.  Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis.

Authors:  N Harada
Journal:  Biochem Biophys Res Commun       Date:  1988-10-31       Impact factor: 3.575

Review 3.  Pituitary disorders during pregnancy.

Authors:  D Prager; G D Braunstein
Journal:  Endocrinol Metab Clin North Am       Date:  1995-03       Impact factor: 4.741

4.  Estrogen-induced tumorigenesis in the Copenhagen rat: disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas.

Authors:  T J Spady; D M Harvell; M C Snyder; K L Pennington; R D McComb; J D Shull
Journal:  Cancer Lett       Date:  1998-02-13       Impact factor: 8.679

5.  Immunohistochemical evidence of the presence of aromatase P450 in the rat hypophysis.

Authors:  J Carretero; G Vázquez; E Blanco; M Rubio; M Santos; A Martín-Clavijo; J L Torres; R Vázquez
Journal:  Cell Tissue Res       Date:  1999-03       Impact factor: 5.249

6.  The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.

Authors:  C J Bagatell; K D Dahl; W J Bremner
Journal:  J Androl       Date:  1994 Jan-Feb

7.  Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen.

Authors:  J C Prior; T A Cox; D Fairholm; E Kostashuk; R Nugent
Journal:  J Clin Endocrinol Metab       Date:  1987-02       Impact factor: 5.958

8.  Study on the relationship between plasma prolactin levels and androgen metabolism in man.

Authors:  B Magrini; J R Ebiner; P Burckhardt; J P Felber
Journal:  J Clin Endocrinol Metab       Date:  1976-10       Impact factor: 5.958

9.  Brain cell nuclear retention of testosterone metabolites, 5alpha-dihydrotestosterone and estradiol-17beta, in adult rats.

Authors:  I Lieberburg; B S McEwen
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

10.  The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.

Authors:  Mary P Gillam; Stewart Middler; Daniel J Freed; Mark E Molitch
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

View more
  13 in total

Review 1.  Neuroestradiol in regulation of GnRH release.

Authors:  Ei Terasawa
Journal:  Horm Behav       Date:  2018-04-19       Impact factor: 3.587

2.  Localization of the aromatase enzyme expression in the human pituitary gland and its effect on growth hormone, prolactin, and thyroid stimulating hormone axis.

Authors:  Asli Sezgin Caglar; Aysegul Kapucu; Kadriye Akgun Dar; Hande Mefkure Ozkaya; Erkan Caglar; Haluk Ince; Pinar Kadioglu
Journal:  Endocrine       Date:  2015-02-20       Impact factor: 3.633

3.  Aromatized Estrogens Amplify Nocturnal Growth Hormone Secretion in Testosterone-Replaced Older Hypogonadal Men.

Authors:  Ferdinand Roelfsema; Rebecca J Yang; Paul Y Takahashi; Dana Erickson; Cyril Y Bowers; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

4.  Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.

Authors:  Hande Mefkure Ozkaya; Nil Comunoglu; Fatma Ela Keskin; Buge Oz; Ozlem Asmaz Haliloglu; Necmettin Tanriover; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

5.  Aromatase cytochrome P450 enzyme expression in prolactinomas and its relationship to tumor behavior.

Authors:  Hakan Akinci; Aysegul Kapucu; Kadriye Akgun Dar; Ozlem Celik; Banu Tutunculer; Gozde Sirin; Buge Oz; Nurperi Gazioglu; Haluk Ince; Süheyla Aliustaoglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

6.  Extraovarian gonadotropin negative feedback revealed by aromatase inhibition in female marmoset monkeys.

Authors:  Marissa Kraynak; Matthew T Flowers; Robert A Shapiro; Amita Kapoor; Jon E Levine; David H Abbott
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-05       Impact factor: 4.310

7.  Aromatase enzyme expression in acromegaly and its possible relationship with disease prognosis.

Authors:  Alev Selek; Berrin Cetinarslan; Yesim Gurbuz; Ilhan Tarkun; Zeynep Canturk; Burak Cabuk
Journal:  Endocrine       Date:  2014-10-10       Impact factor: 3.633

8.  Local transformations of androgens into estradiol by aromatase P450 is involved in the regulation of prolactin and the proliferation of pituitary prolactin-positive cells.

Authors:  María José García Barrado; Enrique J Blanco; Marta Carretero Hernández; María Carmen Iglesias Osma; Manuel Carretero; Julio J Herrero; Deborah Jane Burks; José Carretero
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

Review 9.  Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas.

Authors:  María José García-Barrado; Enrique J Blanco; María Carmen Iglesias-Osma; Marta Carretero-Hernández; Leonardo Catalano-Iniesta; Virginia Sanchez-Robledo; Manuel Carretero; Julio Joaquín Herrero; Sixto Carrero; José Carretero
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

Review 10.  Cognitive Effects of Aromatase and Possible Role in Memory Disorders.

Authors:  Cheryl S Rosenfeld; Dusti A Shay; Victoria J Vieira-Potter
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.